The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: A cross-sectional study

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Qin, Guangming ^a   Tu, Jiangfeng ^a   Zhang, Chenjing ^a   Tang, Xiaoxiao ^a   Luo, Laisheng ^a   Wu, Jiaqi ^a   Liu, Lingang ^a   Lu, Wen ^a   Tao, Lisha ^a   Shen, Shengrong ^b   Das, Undurti N ^c   Pan, Wensheng ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UND LIFE SCIENCES   (United States)

Author keywords

ApoB apoA ; Carotid atherosclerosis; Carotid intima media thickness; Metabolic syndrome; Non HDL C HDL C

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CAROTID ATHEROSCLEROSIS; CHINESE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; METABOLIC SYNDROME X; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CAROTID ARTERY DISEASES; CHINA; COMPLICATION; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHINA; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84927930749     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0023-4     Document Type: Article

References (33)

1. Syvanne M, Taskinen MR. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet. 1997;350:Si20-3.
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome - an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
3. Sengul C, Cevik C, Ozveren O, Oduncu V, Sunbul A, Akgun T, et al. Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome. Echocardiography. 2011;28:853-8.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults - findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
6. Rong D, Jianfei M, Changqing Y, Changyan W, Hongyuan L. morbidity of metaboiism syndrome in middle and aged crowd. Med J west China. 2010;1:130-2.
7. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness - a systematic review and meta-analysis. Circulation. 2007;115:459-67.
8. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol. 1997;146:483-94.
9. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL. carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14-22.
10. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365:213-21.
11. Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, et al. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J. 2007;28:398-406.
12. Dahlen EM, Lanne T, Engvall J, Lindstrom T, Grodzinsky E, Nystrom FH, et al. Carotid intima-media thickness and apolipoprotein b/apolipoprotein a-i ratio in middle-aged patients with type 2 diabetes. Diabet Med. 2009;26:384-90.
13. Huang F, Yang Z, Xu BH, Bi YF, Xu M, Xu Y, et al. Both serum apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I ratio are associated with carotid intima-media thickness. Plos One. 2013;8:e54628.
14. Zhao WW, Gong W, Wu N, Li YT, Ye KP, Lu B, et al. Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese. Lipids Health Dis. 2014;13:37.
15. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, et al. metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004;43:1388-95.
16. McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, et al. Prevalence of coronary heart disease and carotid arterial thickening in. patients with the metabolic syndrome (The ARIC Study). Am J Cardiol. 2004;94:1249-54.
17. Sipila K, Moilanen L, Nieminen T, Reunanen A, Jula A, Salomaa V, et al. Metabolic syndrome and carotid intima media thickness in the health 2000 survey. Atherosclerosis. 2009;204:276-81.
18. Tabatabaei-Malazy O, Fakhrzadeh H, Sharifi F, Mirarefin M, Badamchizadeh Z, Larijani B. Gender differences in association between metabolic syndrome and carotid intima media thickness. J Diabetes Metab Disord. 2012;11:13.
19. Kweon SS, Shin MH, Lee YH, Choi JS, Nam HS, Park KS, et al. Higher normal ranges of urine albumin-to-creatinine ratio are independently associated with carotid intima-media thickness. Cardiovasc Diabetol. 2012;11:112.
20. Alcohol-attributable deaths and years of potential life lost-United States, 2001. MMWR Morb Mortal Wkly Rep 53: 866-870
21. Cleeman JI, Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA, et al. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
22. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Lochen ML, et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The Tromso study. Stroke. 2007;38:2873-80.
23. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Chin J Cardiol. 2011;39:579-614.
24. Ying Y, Qiang Y, Lirong L, Miao W, Wuxiang X, Jiangyi X, et al. Ultrasonic Testing of the Intima Media Thickness (IMT) in the carotid artery-repetitive comments. Ultrasonic Imag Mag. 2010;19:120-3.
25. Kaess BM, Jozwiak J, Mastej M, Lukas W, Grzeszczak W, Windak A, et al. Association between anthropometric obesity measures and coronary artery disease: a cross-sectional survey of 16 657 subjects from 444 polish cities. Heart. 2010;96:131-5.
26. Wassink AMJ, Van Der Graaf Y, Soedamah-Muthu SS, Spiering W, Visseren FLJ, Grp SS. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diab Vasc Dis Res. 2008;5:114-22.
27. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J Intern Med. 2006;259:493-519.
28. Olofsson SO, Wiklund O, Boren J. Apolipoproteins A-I and B: Biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag. 2007;3:491-502.
29. Meisinger C, Loewel H, Mraz W, Koenig W. Prognostic value of Apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J. 2005;26:271-8.
30. Barton M. Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection? Expert Opin Investig Drugs. 2001;10:789-809.
31. Ndumele CE, Matsushita K, Astor B, Virani SS, Mora S, Williams EK, et al. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: The ARIC study. Eur J Prev Cardiol. 2014;21:866-75.
32. Paul TK, Chen W, Srinivasan SR, Toprak A, He J, Berenson GS. Gender divergence on the impact of multiple cardiovascular risk factors on the femoral artery intima-media thickness in asymptomatic young adults: The Bogalusa heart study. Am J Med Sci. 2012;343:40-5.
33. Shaw LJ, Merz CNB, Pepine CJ, Reis SE, Bittner V, Kelsey SF, et al. Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) Study part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47:4S-20S.